查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760697

2025年聚合酵素链锁反应（PCR）分子诊断全球市场报告

Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计聚合酵素链锁反应(PCR) 分子诊断市场规模将在未来几年强劲成长。到 2029 年，该市场规模将成长到 136.4 亿美元，年复合成长率（CAGR）为 8.7%。预测期内的成长可归因于癌症盛行率的上升、对个人化医疗的需求不断增长、对分子诊断的投资不断增加、对快速诊断测试的需求不断增长以及对非侵入性产前检测的需求不断增长。在此期间，预期的主要趋势包括诊断技术的进步、即时聚合酵素链锁反应系统的开发、多重聚合酵素链锁反应的创新、聚合酵素链锁反应与微流体聚合酵素链锁反应平台的技术增强。

感染疾病的日益普及预计将推动聚合酵素链锁反应(PCR) 分子诊断市场的扩张。感染疾病是由细菌、病毒、真菌和寄生虫等有害微生物引起的，可以透过人际直接或间接传播。这些疾病的日益普及主要是由于抗生素抗药性病原体的增多，这使得它们更难以治疗和控制，导致病程延长、医疗成本上升和公共卫生风险增加。 PCR 分子诊断技术能够在基因层面快速且准确地检测病原体，从而改善感染疾病的管理，实现早期诊断和针对性治疗。这透过促进及时介入、遏制感染传播和改善患者照护来改善医疗保健结果。例如，2023年11月，美国政府机构卫生与公众服务部报告称，2022年新报告的慢性乙型肝炎病例与2021年相比增加了11%。因此，感染疾病盛行率的上升正在推动PCR分子诊断市场的成长。

聚合酵素链锁反应(PCR) 分子诊断市场的主要企业正致力于开发桌上型仪器等尖端解决方案，以提高检测效率和可及性。桌上型仪器是实验室级仪器，体积小巧，可放置在工作台或桌子上，专为科学、医疗和工业测试与分析而设计。例如，2024 年 9 月，德国生物技术公司 QIAGEN NV 推出了用于临床肿瘤学检测的 QIAcuityDx 数位 PCR 系统。该系统将分区、热循环和成像功能整合在一台仪器中，并具有全自动、无人值守处理功能。 DNA 和 RNA 的绝对定量分析可在大约两小时内完成，且无需太多手动操作。该系统支援多达五个检测通道，用于多路復用和顺序奈米板加载，并透过提供检验且灵活的研究模式，可适应各种临床和实验室需求。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球聚合酵素链锁反应（PCR）分子诊断PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球聚合酵素链锁反应（PCR）分子诊断市场：成长率分析
  • 全球聚合酵素链锁反应（PCR）分子诊断市场表现：规模与成长，2019-2024年
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球聚合酵素链锁反应（PCR）分子诊断总目标市场（TAM）

第六章市场区隔

  • 全球聚合酵素链锁反应(PCR) 分子诊断市场（按产品类型、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂和耗材
  • 软体
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 即时聚合酵素链锁反应
  • 数位聚合酵素链锁反应
  • 常规聚合酵素链锁反应
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场（依样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 血液样本
  • 唾液样本
  • 组织样本
  • 尿液样本
  • 全球聚合酵素链锁反应（PCR）分子诊断市场的应用、效能及预测（2019-2024年、2024-2029年及2034年）
  • 传染病检查
  • 肿瘤学检测
  • 其他用途
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年及 2034 年
  • 医院
  • 诊断实验室
  • 其他最终用户
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场、仪器、按类型细分：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准聚合酵素链锁反应系统
  • 数聚合酵素链锁反应系统
  • 即时聚合酵素链锁反应系统
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场、试剂和耗材、按类型细分：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应套件
  • 聚合酵素链锁反应酶
  • 聚合酵素链锁反应引子和探针
  • 聚合酵素链锁反应预混液
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场、软体、按类型细分：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应分析软体
  • 资料管理软体

第七章 区域和国家分析

  • 全球聚合酵素链锁反应（PCR）分子诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球聚合酵素链锁反应(PCR) 分子诊断市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 聚合酵素链锁反应（PCR）分子诊断市场：竞争模式
  • 聚合酵素链锁反应（PCR）分子诊断市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Laboratory Corporation of America Holdings
  • Agilent Technologies Inc.
  • Grifols SA
  • Illumina Inc.
  • Endress+Hauser AG
  • bioMereieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QuidelOrtho Corporation
  • PerkinElmer
  • Eppendorf AG
  • Tecan Group
  • Takara Bio Inc.
  • Biocartis NV
  • Zymo Research Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年聚合酵素链锁反应（PCR）分子诊断市场：提供新机会的国家
  • 2029年聚合酵素链锁反应（PCR）分子诊断市场：细分领域带来新机会
  • 聚合酵素链锁反应（PCR）分子诊断市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35574

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory method used to amplify and examine specific sequences of deoxyribonucleic acid or ribonucleic acid in a sample. Its primary function is to detect the presence of targeted genetic material, allowing for the identification of pathogens, genetic conditions, or mutations. This technique is extensively utilized in medical diagnostics due to its high sensitivity and accuracy in detecting infectious diseases, genetic disorders, and cancer-related markers.

The key product categories in PCR molecular diagnostics include instruments, reagents and consumables, and software. Instruments are devices or tools specifically designed for performing scientific, medical, or technical tasks and measurements. The technology includes real-time PCR, digital PCR, and conventional PCR methods, applied to various sample types such as blood, saliva, tissue, and urine. PCR molecular diagnostics are used across different applications, including infectious disease testing and oncology testing, and serve a range of end-users such as hospitals, diagnostic laboratories, and other healthcare facilities.

The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction molecular diagnostics market statistics, including the polymerase chain reaction molecular diagnostics industry's global market size, regional shares, competitors with the polymerase chain reaction molecular diagnostics market share, detailed polymerase chain reaction molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. This polymerase chain reaction molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to the rising demand for early disease detection, a growing prevalence of infectious diseases, heightened awareness of genetic disorders, increased adoption of point-of-care testing, and a higher incidence of chronic illnesses.

The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising demand for personalized medicine, growing investments in molecular diagnostics, increasing need for rapid diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends expected during this period include advancements in diagnostic technologies, development of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, integration of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.

The growing prevalence of infectious diseases is expected to drive the expansion of the polymerase chain reaction (PCR) molecular diagnostics market. Infectious diseases are caused by harmful microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly from person to person. The increasing prevalence of these diseases is largely due to the rise of antibiotic-resistant pathogens, which are more difficult to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. PCR molecular diagnostics improve the management of infectious diseases by offering rapid and accurate pathogen detection at the genetic level, enabling early diagnosis and targeted treatment. This enhances healthcare outcomes by promoting timely interventions, reducing the spread of infections, and improving patient care. For example, in November 2023, the Department of Health and Human Services, a U.S. government agency, reported an 11% increase in newly reported chronic hepatitis B cases in 2022 compared to 2021. As a result, the rising prevalence of infectious diseases is fueling the growth of the PCR molecular diagnostics market.

Leading companies in the polymerase chain reaction (PCR) molecular diagnostics market are focusing on developing cutting-edge solutions, such as benchtop instruments, to improve testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices small enough to fit on a workbench or table, designed for scientific, medical, or industrial testing and analysis. For example, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, introduced the QIAcuityDx Digital PCR System for clinical oncology testing. This system features fully automated, walk-away processing, integrating partitioning, thermocycling, and imaging into a single instrument. It provides absolute quantification of DNA and RNA in about two hours, with minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, making it adaptable to various clinical and laboratory requirements.

In May 2024, Bruker Corporation, a U.S.-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. This acquisition allows Bruker to enhance its presence in infectious disease diagnostics by broadening its molecular diagnostic capabilities and product portfolio, enabling it to better serve clinical laboratories and hospitals worldwide. ELITech Group SAS is an Italy-based in-vitro diagnostics company, specializing in polymerase chain reaction (PCR) molecular diagnostics.

Major players in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, and Zymo Research Corporation.

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polymerase chain reaction molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polymerase chain reaction molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instrument; Reagents And Consumables; Software
  • 2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
  • 3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
  • 4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
  • 5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
  • 2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
  • 3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction Molecular Diagnostics Market Characteristics

3. Polymerase Chain Reaction Molecular Diagnostics Market Trends And Strategies

4. Polymerase Chain Reaction Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polymerase Chain Reaction Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Polymerase Chain Reaction Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Polymerase Chain Reaction Molecular Diagnostics Market Growth Rate Analysis
  • 5.4. Global Polymerase Chain Reaction Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Polymerase Chain Reaction Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Polymerase Chain Reaction Molecular Diagnostics Total Addressable Market (TAM)

6. Polymerase Chain Reaction Molecular Diagnostics Market Segmentation

  • 6.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instrument
  • Reagents And Consumables
  • Software
  • 6.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time Polymerase Chain Reaction
  • Digital Polymerase Chain Reaction
  • Conventional Polymerase Chain Reaction
  • 6.3. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Samples
  • Saliva Samples
  • Tissue Samples
  • Urine Samples
  • 6.4. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease Testing
  • Oncology Testing
  • Other Applications
  • 6.5. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Other End Users
  • 6.6. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Polymerase Chain Reaction Systems
  • Digital Polymerase Chain Reaction Systems
  • Real-Time Polymerase Chain Reaction Systems
  • 6.7. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction Kits
  • Polymerase Chain Reaction Enzymes
  • Polymerase Chain Reaction Primers And Probes
  • Polymerase Chain Reaction Master Mix
  • 6.8. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction Analysis Software
  • Data Management Software

7. Polymerase Chain Reaction Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market

  • 8.1. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction Molecular Diagnostics Market

  • 9.1. China Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 9.2. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction Molecular Diagnostics Market

  • 10.1. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction Molecular Diagnostics Market

  • 11.1. Japan Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 11.2. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction Molecular Diagnostics Market

  • 12.1. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market

  • 13.1. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction Molecular Diagnostics Market

  • 14.1. South Korea Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 14.2. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market

  • 15.1. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 15.2. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction Molecular Diagnostics Market

  • 16.1. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction Molecular Diagnostics Market

  • 17.1. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction Molecular Diagnostics Market

  • 18.1. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction Molecular Diagnostics Market

  • 19.1. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction Molecular Diagnostics Market

  • 20.1. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market

  • 21.1. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 21.2. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction Molecular Diagnostics Market

  • 22.1. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction Molecular Diagnostics Market

  • 23.1. North America Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 23.2. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction Molecular Diagnostics Market

  • 24.1. USA Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 24.2. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction Molecular Diagnostics Market

  • 25.1. Canada Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 25.2. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction Molecular Diagnostics Market

  • 26.1. South America Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 26.2. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction Molecular Diagnostics Market

  • 27.1. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction Molecular Diagnostics Market

  • 28.1. Middle East Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 28.2. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction Molecular Diagnostics Market

  • 29.1. Africa Polymerase Chain Reaction Molecular Diagnostics Market Overview
  • 29.2. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape
  • 30.2. Polymerase Chain Reaction Molecular Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction Molecular Diagnostics Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings
  • 31.2. Agilent Technologies Inc.
  • 31.3. Grifols S.A.
  • 31.4. Illumina Inc.
  • 31.5. Endress + Hauser AG
  • 31.6. bioMereieux SA
  • 31.7. Sysmex Corporation
  • 31.8. Bio-Rad Laboratories Inc.
  • 31.9. QuidelOrtho Corporation
  • 31.10. PerkinElmer
  • 31.11. Eppendorf AG
  • 31.12. Tecan Group
  • 31.13. Takara Bio Inc.
  • 31.14. Biocartis NV
  • 31.15. Zymo Research Corporation

32. Global Polymerase Chain Reaction Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market

34. Recent Developments In The Polymerase Chain Reaction Molecular Diagnostics Market

35. Polymerase Chain Reaction Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer